Actinoidin: a new inhibitor of ristocetin- and ristomycin-induced platelet agglutination |
| |
| Authors: | Z Boda N O Solum F Sztaricskai K Rak |
| |
| Affiliation: | 1. IInd Department of Medicine, University Medical School, Debrecen, Hungary;2. Research Institute for Internal Medicine, University of Oslo, Rikshospitalet, Oslo 1, Norway;3. The Research Group of Antibiotics, Hungarian Academy of Sciences, Lajos Kossuth University, Debrecen, Hungary |
| |
| Abstract: | Actinoidin, like vancomycin, inhibits ristocetin-and ristomycin-induced VIIIR:WF-dependent agglutination of untreated or formaldehyde-fixed human platelets but does not interfere with bovine factor VIII-induced agglutination. The socalled “direct effect” of ristocetin and ristomycin on fixed platelets, which is represented by an immediate increase in light absorbancy in the absence of cofactor, was not blocked by actinoidin at concentrations which totally inhibited agglutination in the presence of VIIIR:WF. Actinoidin does not inhibit thrombin-induced platelet aggregation. This represents a further argument against a common platelet membrane receptor site for thrombin and ristocetin or a ristocetin-VIIIR:WF complex on the platelet membrane. |
| |
| Keywords: | Actinoidin platelet agglutination inhibitor |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
